NewsNectar Lifesciences Receives Favorable Order in Income Tax Assessment Matter for AY 2017-18Nectar Lifesciences Receives Favorable Order in Income Tax Assessment Matter for AY 2017-18
Nectar Lifesciences Limited has received a favorable order from the Deputy Commissioner of Income Tax, Chandigarh, disposing of its assessment matter for Assessment Year 2017-18 with no financial implications. This concludes a multi-year litigation process that began with challenges to income tax notices under Sections 148 and 148A(b) covering Assessment Years 2017-18 to 2021-22. The company had previously secured favorable orders from the Punjab and Haryana High Court for other assessment years in May 2025, and now with this final order dated March 31, 2026, the entire matter stands fully concluded.
*this image is generated using AI for illustrative purposes only.
Nectar lifesciences Limited has successfully concluded its income tax assessment litigation with a favorable order from the Deputy Commissioner of Income Tax (DCIT), Chandigarh. The pharmaceutical company announced that the DCIT disposed of the assessment matter for Assessment Year 2017-18 in the company's favor through an order dated March 31, 2026.
Case Background and Timeline
The litigation originated when Nectar Lifesciences challenged notices issued under Sections 148 and 148A(b) of the Income Tax Act, 1961, covering Assessment Years 2017-18 to 2021-22. The company filed a writ petition before the Punjab and Haryana High Court, which directed the Income Tax Department to dispose of the company's objections within eight weeks.
| Assessment Years: | Status | Order Date |
|---|---|---|
| 2018-19 to 2021-22: | Favorable orders received | May 1, 2025 and May 7, 2025 |
| 2017-18: | Objections decided in favor | March 31, 2026 |
Recent Development Details
The Deputy Commissioner of Income Tax, Central Circle-1, Chandigarh, issued the favorable order for Assessment Year 2017-18 on March 31, 2026. The company received this order via email on April 9, 2026. According to the company's disclosure, this order has no expected financial implications, with the quantum of claims listed as NIL.
Financial Impact and Conclusion
The favorable resolution carries no financial burden for Nectar Lifesciences. The company confirmed that with this latest order, the entire matter stands fully concluded across all contested assessment years.
| Parameter: | Details |
|---|---|
| Opposing Party: | Deputy Commissioner of Income Tax, Chandigarh |
| Expected Financial Implication: | NIL |
| Quantum of Claims: | NIL |
| Current Status: | Matter fully concluded |
Disclosure Timeline
The company acknowledged a delay in providing these details to the stock exchanges, attributing it to temporary inaccessibility of a registered email ID of a former employee who had left the organization. Nectar Lifesciences expressed regret for the omission and assured the exchanges of its commitment to furnishing all material information within prescribed time limits in the future.
This successful resolution of the income tax assessment matter removes a potential regulatory overhang for the pharmaceutical company, allowing it to focus on its core business operations without the burden of ongoing tax litigation.
Historical Stock Returns for Nectar Lifesciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.59% | +1.55% | +26.89% | -21.26% | -44.10% | -51.99% |
How might this favorable tax resolution impact Nectar Lifesciences' future compliance strategy and relationship with tax authorities?
Will the removal of this regulatory overhang enable the company to pursue new business expansion or investment opportunities?
What measures is Nectar Lifesciences implementing to prevent future disclosure delays following this email accessibility issue?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
